Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
International Journal of Infectious Diseases
Published October 21, 2026
SARS-CoV-2 Seroprevalence and Antibody Dynamics in The Gambia During the Transition from Pandemic...
October 23, 2026
Medspoke
Medspoke
Gastric Cancer
Published October 21, 2026
00:00
--:--
Beyond 30-day mortality: causes and risk factors of half-year postdischarge mortality after gastr...
October 23, 2026
Share
Beyond 30-day mortality: causes and risk factors of half-year postdischarge mortality after gastric cancer surgery.
https://www.medspoke.co/channel_journal?id=785&tap_id=16100
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Gastroenterology
Published October 21, 2026
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer.
October 23, 2026
Why are you reporting this TALK?
